Evolus Inc (EOLS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $4.49
• Market Cap: $291.69M
• EPS: $-0.94
• 52-Week High: $14.94
• 52-Week Low: $4.09

Market Sentiment

Evolus Inc currently has a Bullish sentiment score of 0.22.

About Evolus Inc

Evolus, Inc. is a dynamic aesthetic medical company based in Newport Beach, California, renowned for its innovative beauty solutions tailored for healthcare providers and their patients. The company’s flagship product, Jeuveau, is a neurotoxin uniquely developed for the cosmetic market, demonstrating Evolus's commitment to quality and efficacy in enhancing aesthetic results. As a pivotal entity within the expanding aesthetic industry, Evolus is focused on broadening its portfolio and penetrat...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Evolus Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EOLS pay dividends?

Evolus Inc (EOLS) does not currently pay a regular dividend.

What is EOLS's market cap?

Evolus Inc (EOLS) has a market capitalization of $291.69M with a current stock price of $4.49.